Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Langer

Showing results (131-140 of 160) with videos related to

Pageof 16
Sort By:
Bioanalysis|September 27, 2022
Accelerator mass spectrometry for quantification of micro- and therapeutic-dose diclofenac in microdialysis samplesOliver Langer, Jinho Song, Min Sun Choi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 4, 2005
In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PETOliver Langer, Martin Brunner, Markus Zeitlinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 21, 2015
[18F]FE@SUPPY: a suitable PET tracer for the adenosine A3 receptor? An in vivo study in rodentsDaniela Haeusler, Claudia Kuntner, Lukas Nics, et al.
Molecular Pharmaceutics|December 3, 2019
Measurement of Hepatic ABCB1 and ABCG2 Transport Activity with [<sup>11</sup>C]Tariquidar and PET in Humans and MiceIrene Hernández Lozano, Martin Bauer, Beatrix Wulkersdorfer, et al.
Clinical Pharmacology and Therapeutics|August 9, 2005
Influence of functional haplotypes in the drug transporter gene ABCB1 on central nervous system drug distribution in humansMartin Brunner, Oliver Langer, Raute Sunder-Plassmann, et al.
EMBO Molecular Medicine|October 27, 2018
EGFR is required for FOS-dependent bone tumor development via RSK2/CREB signalingMarkus Linder, Elisabeth Glitzner, Sriram Srivatsa, et al.
Frontiers in Bioengineering and Biotechnology|October 5, 2020
Tobacco Smoke and Inhaled Drugs Alter Expression and Activity of Multidrug Resistance-Associated Protein-1 (MRP1) in Human Distal Lung Epithelial Cells <i>in vitro</i>Mohammed Ali Selo, Anne-Sophie Delmas, Lisa Springer, et al.
Neurology|September 5, 2014
In vivo P-glycoprotein function before and after epilepsy surgeryMartin Bauer, Rudolf Karch, Markus Zeitlinger, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 21, 2020
Complete inhibition of ABCB1 and ABCG2 at the blood-brain barrier by co-infusion of erlotinib and tariquidar to improve brain delivery of the model ABCB1/ABCG2 substrate [<sup>11</sup>C]erlotinibNicolas Tournier, Sebastien Goutal, Severin Mairinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2018
A Proof-of-Concept Study to Inhibit ABCG2- and ABCB1-Mediated Efflux Transport at the Human Blood-Brain BarrierMartin Bauer, Rudolf Karch, Beatrix Wulkersdorfer, et al.
Pageof 16

Showing results (131-140 of 160) with videos related to

Sort By:
Pageof 16
Bioanalysis|September 27, 2022
Accelerator mass spectrometry for quantification of micro- and therapeutic-dose diclofenac in microdialysis samplesOliver Langer, Jinho Song, Min Sun Choi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 4, 2005
In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PETOliver Langer, Martin Brunner, Markus Zeitlinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 21, 2015
[18F]FE@SUPPY: a suitable PET tracer for the adenosine A3 receptor? An in vivo study in rodentsDaniela Haeusler, Claudia Kuntner, Lukas Nics, et al.
Molecular Pharmaceutics|December 3, 2019
Measurement of Hepatic ABCB1 and ABCG2 Transport Activity with [<sup>11</sup>C]Tariquidar and PET in Humans and MiceIrene Hernández Lozano, Martin Bauer, Beatrix Wulkersdorfer, et al.
Clinical Pharmacology and Therapeutics|August 9, 2005
Influence of functional haplotypes in the drug transporter gene ABCB1 on central nervous system drug distribution in humansMartin Brunner, Oliver Langer, Raute Sunder-Plassmann, et al.
EMBO Molecular Medicine|October 27, 2018
EGFR is required for FOS-dependent bone tumor development via RSK2/CREB signalingMarkus Linder, Elisabeth Glitzner, Sriram Srivatsa, et al.
Frontiers in Bioengineering and Biotechnology|October 5, 2020
Tobacco Smoke and Inhaled Drugs Alter Expression and Activity of Multidrug Resistance-Associated Protein-1 (MRP1) in Human Distal Lung Epithelial Cells <i>in vitro</i>Mohammed Ali Selo, Anne-Sophie Delmas, Lisa Springer, et al.
Neurology|September 5, 2014
In vivo P-glycoprotein function before and after epilepsy surgeryMartin Bauer, Rudolf Karch, Markus Zeitlinger, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 21, 2020
Complete inhibition of ABCB1 and ABCG2 at the blood-brain barrier by co-infusion of erlotinib and tariquidar to improve brain delivery of the model ABCB1/ABCG2 substrate [<sup>11</sup>C]erlotinibNicolas Tournier, Sebastien Goutal, Severin Mairinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2018
A Proof-of-Concept Study to Inhibit ABCG2- and ABCB1-Mediated Efflux Transport at the Human Blood-Brain BarrierMartin Bauer, Rudolf Karch, Beatrix Wulkersdorfer, et al.
Pageof 16